The primary mission of MPN Research Foundation is to promote, fund and support the most innovative and effective research into the causes, treatments, and potentially the cure for ET, PV, and MF. Read about our commitment to help make 2013 a banner year for MPN science.
We have partnered with the Leukemia & Lymphoma Society to stop or reverse fibrosis and find a cure for myelofibrosis. More information about this MF Challenge is available here:
10 December 2013 Phase 2 results of Pacritinib released at ASH Annual Meeting
10 December 2013 Geron reports on progress of telomerase inhibitor
18 November 2013 Sanofi discontinues all MPN drug trials